Teladoc price target raised to $29 from $27 at Deutsche Bank

Deutsche Bank analyst George Hill raised the firm’s price target on Teladoc to $29 from $27 and keeps a Hold rating on the shares following the Q1 report. The analyst believes the company is likely at a near term operating bottom.